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Endothelial-speciﬁc inhibition of NF-kB
enhances functional haematopoiesis
Michael G. Poulos1,2, Pradeep Ramalingam1,2, Michael C. Gutkin1,2, Maria Kleppe3, Michael Ginsberg4,
Michael J.P. Crowley5,6,7, Olivier Elemento8, Ross L. Levine3,9,10, Shahin Raﬁi11, Jan Kitajewski12,13,
Matthew B. Greenblatt14, Jae-Hyuck Shim15 & Jason M. Butler1,2
Haematopoietic stem cells (HSCs) reside in distinct niches within the bone marrow (BM)
microenvironment, comprised of endothelial cells (ECs) and tightly associated perivascular
constituents that regulate haematopoiesis through the expression of paracrine factors. Here
we report that the canonical NF-kB pathway in the BM vascular niche is a critical signalling
axis that regulates HSC function at steady state and following myelosuppressive insult, in
which inhibition of EC NF-kB promotes improved HSC function and pan-haematopoietic
recovery. Mice expressing an endothelial-speciﬁc dominant negative IkBa cassette under the
Tie2 promoter display a marked increase in HSC activity and self-renewal, while promoting
the accelerated recovery of haematopoiesis following myelosuppression, in part through
protection of the BM microenvironment following radiation and chemotherapeutic-induced
insult. Moreover, transplantation of NF-kB-inhibited BM ECs enhanced haematopoietic
recovery and protected mice from pancytopenia-induced death. These ﬁndings pave the way
for development of niche-speciﬁc cellular approaches for the treatment of haematological
disorders requiring myelosuppressive regimens.
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A
dult haematopoietic stem cells (HSCs) are deﬁned by their
ability to undergo self-renewal and maintain the capacity
to generate all mature haematopoietic cell types within
the blood and immune system1,2. These unique qualities make the
HSC clinically useful in bone marrow (BM) transplantation
settings for a wide variety of haematological diseases3,4. There is a
large body of evidence demonstrating a functional interaction
between the tissue-speciﬁc microenvironment and its resident
HSC, which modulates stem cell quiescence, self-renewal and
differentiation5,6. Despite advances in the understanding of
HSC biology, the exact intrinsic and extrinsic mechanisms that
regulate the balance between self-renewal and lineage-speciﬁc
differentiation are still unknown2. Elucidating the mechanisms
utilized by the BM microenvironment to regulate HSC fate aim to
improve upon current strategies for the ex vivo expansion
of transplantable, repopulating HSCs for the treatment of
life-threatening pancytopenia associated with chemo-irradiation
and to facilitate the development of therapeutic approaches
to accelerate the regeneration of the BM niche and the HSC pool
in vivo following myeloablation.
Endothelial cells have a critical role in regulating haemato-
poiesis throughout life, from the embryonic emergence of
deﬁnitive HSCs to supporting haematopoietic homeostasis and
regeneration following myeloablative injury7–9. However, the
comprehensive signalling framework within the endothelial niche
that supports HSC maintenance and function are not fully
understood2,5,10. Within the adult BM microenvironment,
endothelial cells are a critical component of niche-mediated
HSC maintenance through expression of pro-haematopoietic
paracrine factors, including KITL, CXCL12, and JAGGED1
(refs 9,11,12). Additionally, signalling through AKT and MAPK
pathways within endothelial cells have been shown to modulate
HSC maintenance. AKT-activation endows endothelial cells with
the capacity to instructively support HSC self-renewal through
the expression of pro-haematopoietic paracrine factors during
both homeostatic haematopoiesis and regeneration of the
haematopoietic system following myelosuppressive stress13–15.
Emerging evidence suggests that the inﬂammatory signals arising
from BM endothelium during pan-haematopoietic injury can also
modify HSC function16,17.
The nuclear factor (NF)-kB family of transcription factors
serve as master regulators of the inﬂammatory response and
have essential roles in haematopoiesis, including embryonic
haematopoietic stem and progenitor cell (HSPC) emergence as
well as survival and differentiation of haematopoietic precur-
sors18–20. Under conditions such as bacterial infections, endo-
thelial and immune cells express inﬂammatory cytokines that
activate HSPCs in the BM niche21,22. Many of these cytokines are
induced by canonical NF-kB signalling, including interleukin
(IL)6, tumour-necrosis factor (TNF)a, interferon (IFN)g,
transforming growth factor (TGF)b, and macrophage colony-
stimulating factor (M-CSF), and can regulate the proliferation
and differentiation of HSPCs23–27. These signals enable the
robust production of immune cells essential to counter and
resolve infection. However, sustained inﬂammatory signalling
has been shown to be detrimental to long-term HSC
maintenance, resulting in a decline in their number and quality,
HSC exhaustion and the emergence of haematopoietic
neoplasms28–30. Based upon the physical proximity of HSCs
and endothelial cells in the BM microenvironment, paracrine
inﬂammatory signals derived from endothelial cells have been
presumed to inﬂuence HSC function29,30. Endothelial cells are
continuously exposed to endogenously produce inﬂammatory
signals, such as advanced glycation end products and products of
extracellular matrix breakdown like hyaluronate31. These
advanced glycation end products and extracellular matrix
components engage toll-like receptor 4 resulting in secretion
of pro-inﬂammatory cytokines such as TNFa and IL6 that
activate NF-kB signalling. Following insult to the BM
microenvironment, endothelial cells produce IL1, resulting in
HSC differentiation and myelopoiesis17. Chronic IL1 exposure
has been shown to severely compromise HSC self-renewal,
which is reversible upon IL1 withdrawal. In endothelial cells,
NF-kB serves as a master regulator of induced expression of a
vast repertoire of inﬂammatory cytokines22,32,33. Therefore,
suppression of canonical NF-kB signalling speciﬁcally in
endothelium could potentially rescue inﬂammatory signalling-
mediated HSC defects17.
In this study, we examine the role of canonical NF-kB
signalling in the maintenance and regeneration of haematopoiesis
mediated by BM endothelial cells. Under steady state conditions,
NF-kB inhibition augments HSC function by increasing the
number of cells in quiescence and enhancing self-renewal.
Moreover, the targeted inhibition of NF-kB in endothelial cells
promotes rapid haematopoietic recovery following myelosup-
pressive injury, maintaining the integrity of the BM microenvir-
onment, and mitigating damage to the BM endothelial cell niche.
Protection of haematopoiesis and the BM vascular niche was also
observed following the infusion of exogenous NF-kB-inhibited
BM-derived endothelial cells (BMECs) in mice subjected to
myeloablative doses of irradiation. Taken together, these results
identify canonical NF-kB as a mediator of BM vascular niche
function that can be modulated to enhance haematopoietic
recovery following pan-haematopoietic insult.
Results
Endothelial NF-jB signalling modulates HSC activity ex vivo.
To explore the possibility that NF-kB signalling in endothelial
cells regulate HSPC function, we used our recently described
ex vivo platform in which HSPCs are co-cultured on a feeder layer
of murine BMECs in serum-free conditions34, allowing for the
modulation of NF-kB signalling speciﬁcally in BMECs. To this
end, we suppressed canonical NF-kB signalling in BMECs and
assessed their ability to maintain and expand functional HSPCs.
At rest, canonical NF-kB transcription factors are sequestered in
the cytoplasm by the IkB complex. Following pathway activation,
IkBa is phosphorylated at serine 32 (S32) and serine 36 (S36) by
the IkB kinase (IKK), ubiquitinated, and ultimately targeted
for proteasomal degradation, freeing NF-kB for translocation to
the nucleus and activation of target genes via its interaction with
kB binding sites in the genome35. To determine if constitutive
inhibition of endothelial-speciﬁc canonical NF-kB signalling is
sufﬁcient to enhance the ex vivo expansion of repopulating HSCs,
we used a dominant negative IkBaS32A/S36A super suppressor
(IkB-SS) construct that irreversibly binds NF-kB (p65/p50) in the
cytoplasm36,37. IkB-SS protein was resistant to TNFa-mediated
degradation in lentiviral-transduced IkB-SS BMECs (Supple-
mentary Fig. 1a,b), inhibiting the nuclear translocation of NF-kB
(p65) (Supplementary Fig. 1c,d), and functionally suppressing
canonical NF-kB-mediated gene expression of cytokines known
to support differentiation of HSPCs (Supplementary Fig. 1e,f)
while maintaining expression of the pro-haematopoietic NOTCH
ligand, JAGGED-1 (Supplementary Fig. 2a–c)9,14. To rule out
NF-kB pathway crosstalk in our platform, we also examined non-
canonical NF-kB signalling in IkB-SS BMECs. Following the
stimulation of the non-canonical NF-kB pathway, NF-kB2
subunit p100 undergoes proteolytic cleavage to form p52/RelB
heterodimers, activating a unique set of NF-kB genes38.
Inhibition of canonical NF-kB in IkB-SS BMECs had no effect
on non-canonical NF-kB signalling, ruling out IkB-SS transgene-
mediated NF-kB crosstalk (Supplementary Fig. 1g–i). To examine
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whether canonical NF-kB signalling in the endothelial niche
functionally alters HSPC maintenance, we utilized our ex vivo
BMEC co-culture platform34. IkB-SS-transduced BMECs were
co-cultured with cKITþLineageSCA1þ (KLS) HSPCs derived
from CD45.2 mice for nine days in serum-free conditions with
exogenous soluble KITL (sKITL), and HSPC activity was assayed.
IkB-SS-transduced BMECs were less capable of promoting total
haematopoietic cell expansion (Fig. 1a), with no signiﬁcant
changes in phenotypic lineage negative or HSPC expansion
(Fig. 1b,c). In agreement with lineage negative cell quantiﬁcation,
there were no observable differences in haematopoietic
progenitor activity in HSPCs co-cultured on IkB-SS-transduced
BMECs (Fig. 1d). To assess long-term repopulating activity, we
transplanted 105 total CD45.2þ co-cultured haematopoietic cells
with 5 105 CD45.1þ whole bone marrow (WBM) cells into
lethally-irradiated CD45.1þ recipients and assessed multi-lineage
engraftment at four months post-transplant. HSPCs cultured
on IkB-SS-transduced BMECs displayed a dramatic increase
in engraftment with no changes in their multi-lineage potential
(Fig. 1e,f), demonstrating that NF-kB suppression within
endothelial cells supports the ex vivo culture of genuine
repopulating HSCs without creating a lineage-commitment bias.
Conversely, pre-activation of canonical NF-kB signalling in
endothelium with TNFa before expansion led to an increase in
total CD45þ and lineage-committed haematopoietic cells, and a
decrease in total phenotypic HSPCs (Supplementary Fig. 3a–e).
Taken together, canonical NF-kB signalling in endothelium can
modulate HSPC activity ex vivo, suggesting that suppressing
canonical NF-kB activity in the BM vascular niche could improve
the overall function of HSCs.
Endothelial NF-jB inhibition enhances HSPC function in vivo.
To assess the role of NF-kB signalling within the in vivo BM
endothelial niche, we employed a previously described transgenic
mouse model in which NF-kB signalling is inhibited speciﬁcally
in endothelial cells by expressing the IkB-SS dominant negative
construct under the transcriptional control of the Tie2 promoter
(Tie2::IkB-SS)39. Under steady state conditions, Tie2::IkB-SS mice
demonstrated a signiﬁcant increase in total haematopoietic cells
per femur (Fig. 2a), while maintaining similar ratios of myeloid
and lymphoid cells in the peripheral blood (Fig. 2b). To examine
the possibility that an increase in BM cellularity was associated
with an increase in HSPC activity, we tested homeostatic
HSPC function. WBM derived from wild-type (WT) control
and Tie2::IkB-SSmice were cultured in semi-solid methylcellulose
and scored for colony-forming units (CFU). Tie2::IkB-SS
mice displayed a signiﬁcant increase in CFU-M, CFU-GM,
CFU-GEMM and overall CFU activity (Fig. 2c). In addition
to an increase in the overall haematopoietic cell content and
progenitor activity, Tie2::IkB-SS mice displayed a greater than
threefold increase in the frequency of phenotypic HSCs
(cKITþLineageSCA1þCD150þCD48 ) (Fig. 2d,e), of which
signiﬁcantly more Tie2::IkB-SS HSCs were in G0 quiescence
(Fig. 2f,g). HSCs in quiescence are associated with an increase in
long-term engraftment potential40; to this end, we tested the
reconstitution ability of HSCs from Tie2::IkB-SS mice by
performing a limiting dilution transplantation of KLS cells and
assessed their long-term engraftment. We found a threefold
increase in the frequency of long-term, multi-lineage
repopulating cells in Tie2::IkB-SS mice (1/26 WT versus 1/9
Tie2::IkB-SS) (Fig. 2h,i), demonstrating that the observed
expansion of phenotypic HSCs in Tie2::IkB-SS mice is
associated with an increase in the frequency of bona ﬁde long-
term, multi-lineage repopulating HSCs. The increased frequency
of HSCs and overall increase in quiescence in Tie2::IkB-SS mice
suggests that under regenerative stress, inhibiting NF-kB
signalling in endothelium may reduce the rate of premature
exhaustion of HSCs. To address this, control and Tie2::IkB-SS
mice were administered low doses of the myelosuppressive agent
5-ﬂuorouracil (5-FU; 150mg kg 1) weekly to induce cycling of
HSCs and serially exhaust the HSC pool. Survival was monitored
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Figure 1 | NF-jB inhibition in endothelium supports HSC activity ex vivo. HSPCs (cKITþLineageSCA1þ ) were co-cultured ex vivo on control or IkB-SS-
transduced BMECs in serum-free conditions with soluble KITL (sKITL) for nine days. (a–c) Co-cultures were analysed for (a) total haematopoietic cells,
(b) lineage negative haematopoietic cells and (c) phenotypic HSPC expansion by ﬂow cytometry (n¼ 3). (d) Haematopoietic progenitor activity in
BMEC-HSPC co-cultures was measured by colony-forming units (CFUs) in methylcellulose (n¼ 3 per expansion). (e,f) HSC activity was quantiﬁed in a
competitive repopulation assay by analysing (e) long-term engraftment and (f) multi-lineage potential in peripheral blood four months post-transplant
(n¼ 10 per expansion). Error bars represent mean±s.e.m. *Po0.05, **Po0.01, ***Po0.001. Pairwise comparisons were performed using Student’s t-test;
biological replicates.
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for each cohort, with all control mice succumbing to
haematopoietic failure by week 19. In contrast, haematopoietic
failure was delayed in Tie2::IkB-SS mice as evidenced by their
60% survival at week 20 (Fig. 2j), suggesting that endothelial-
speciﬁc inhibition of NF-kB signalling promotes the self-renewal
of HSCs under regenerative conditions.
Previous reports have suggested that HSCs express Tie2
(ref. 41). To rule out the possibility that the observed increase in
HSC activity and regenerative capacity is due to HSC-speciﬁc NF-
kB inhibition, we examined NF-kB activity in HSCs and BMECs.
Phenotypic HSCs from control and Tie2::IkB-SS mice revealed
diminutive levels of Tie2 expression (Fig. 3a), and maintained their
NF-kB signalling capacity following TNFa activation, as measured
by phosphorylation of the NF-kB subunit p65 (Fig. 3a). TIE2þ
BMECs isolated from Tie2::IkB-SS mice were unresponsive to
TNFa-mediated NF-kB activation, conﬁrming the endothelial
lineage speciﬁcity of Tie2-driven NF-kB suppression (Fig. 3b)
within the vascular niche. To further conﬁrm that the increase in
HSC activity in Tie2::IkB-SS mice is not due to cell autonomous
inhibition of NF-kB, we transplanted equal numbers of WT control
WBM into lethally irradiated Tie2::IkB-SS recipients and Tie2::IkB-
SS WBM into lethally irradiated control recipients. Despite a
decrease in the frequency of donor-derived HSCs from WTmice at
steady state (B127 HSCs per 106 WBM; Fig. 2d), WT WBM-
Tie2::IkB-SS recipients displayed an increase in HSC frequency
(B164 HSCs per 106 WBM; Fig. 3d) and total haematopoietic
cells per femur (Fig. 3c) four months post-transplant when
compared with reciprocally transplanted mice. These data conﬁrm
that suppression of NF-kB signalling speciﬁcally within BM
endothelium promotes HSC expansion.
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Figure 2 | Endothelial-speciﬁc NF-jB inhibition augments homeostatic HSPC activity in vivo. Adult Tie2::IkB-SS and littermate control mice (12–16
weeks) were assayed at steady state for haematopoietic stem and progenitor cell (HSPC) activity. (a) Total haematopoietic cell counts per femur
(n¼ 5). (b) Percentages of lineage committed haematopoietic cells in the peripheral blood, as determined by ﬂow cytometry (n¼ 5). (c) Analysis of
haematopoietic progenitor activity, as measured by colony-forming units (CFUs) from whole bone marrow (WBM) in methylcellulose (n¼ 6).
(d) Quantiﬁcation of phenotypic haematopoietic stem cells (HSCs; cKITþ LineageSCA1þCD150þCD48 ) from WBM by ﬂow cytometry (n¼ 5).
(e) Representative contour ﬂow plots of phenotypic HSCs from wild-type (WT) and Tie2::IkB-SS mice. (f) Quantiﬁcation of cell cycle state of phenotypic
HSCs. Percentages represent cells in G0 phase. (g) Representative cell cycle contour plots of phenotypic HSCs from WTand Tie2::IkB-SS mice. (h) Limiting
dilution data demonstrating the frequency of long-term multi-lineage reconstitution of phenotypically deﬁned HSPCs (KLS; cKITþ LineageSCA1þ )
(n¼ 20 recipients per cell dose; biological triplicates). (i) A log-fraction plot of the limiting dilution analysis. Dashed lines indicate 95% conﬁdence intervals
(n¼ 20 recipients per cell dose; biological triplicates). (j) Survival curve following weekly administration of 5-ﬂuorouracil (5-FU) (n¼ 20). Error bars
represent mean±s.e.m. *Po0.05, **Po0.01, ***Po0.001. Pairwise comparisons were performed using Student’s t-test; biological replicates.
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BMEC NF-jB inhibition is sufﬁcient to augment HSC activity.
The HSC supportive BM vascular niche is composed of endo-
thelial cells and intimately associated perivascular constituents,
including LEPRþ cells, NESTINþ cells and megakaryocytes5.
Experiments designed to delete BM niche cell-speciﬁc factors or
ablate candidate cell types to explore discrete niche-HSC
interactions can potentially disrupt the signalling framework
within the microenvironment, resulting in unwanted changes to
the numbers and function of other niche constituents. To conﬁrm
that NF-kB inhibition in BMECs is sufﬁcient, independent of
perivascular niche constituents, to promote the observed
expansion of the HSC pool in vivo, we co-cultured WT HSPCs
on BMECs derived from control or Tie2::IkB-SS mice under
serum-free conditions with exogenous sKITL ex vivo. Unlike
Tie2::IkB-SS mice at steady state (Fig. 2a,d), ex vivo expanded
HSPCs revealed no signiﬁcant differences in total CD45þ or
phenotypic KLS populations (Supplementary Fig. 4a–c). Total
expanded haematopoietic cells consisted primarily of myeloid
lineages in both control and Tie2::IkB-SS BMEC co-cultures, with
a signiﬁcant increase in CD41þ megakaryocytes at the expense of
CD11Bþ cells (Supplementary Fig. 4d,g,h). However, similar to
in vivo Tie2::IkB-SS mice, HSPCs co-cultured with Tie2::IkB-SS
BMECs demonstrated more phenotypic HSPCs in G0 quiescence
than HSPCs expanded on control BMECs (Supplementary
Fig. 4e,f). To examine the long-term repopulating activity of
Tie2::IkB-SS expanded HSPCs, we transplanted control BMEC
and Tie2::IkB-SS BMEC-expanded CD45.2þ haematopoietic cells
in primary and secondary competitive repopulation assays
(Supplementary Fig. 4i,j). Tie2::IkB-SS BMEC-expanded HSPCs
displayed a signiﬁcant increase in long-term engraftment
potential, with both control and Tie2::IkB-SS expansions
maintaining multi-lineage potential. These data demonstrate
that NF-kB inhibition in endothelial cells is sufﬁcient to drive the
observed increase in functional HSPCs and preservation of their
self-renewal capabilities in vivo. Taken together, NF-kB signalling
in the vascular niche is sufﬁcient to modulate HSC and
progenitor activity, suggesting that inhibition of NF-kB
signalling in endothelial cells may be an effective therapy
following myelosuppressive injury.
NF-jB-inhibition protects the BM following myelosuppression.
To determine whether endothelial NF-kB signalling inﬂuences
post-myelosuppressive haematopoietic reconstitution, we sub-
jected Tie2::IkB-SS and littermate control mice to sublethal irra-
diation (650 Rads) and assayed for haematopoietic recovery.
Following irradiation, control BMECs (CD45TER119
VECADþ ) demonstrated a transient spike in NF-kB signalling
followed by a decrease, and ultimately returning to homeostatic
levels by day 28 (Fig. 4a), which is consistent with a reported
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increase in WBM TNFa expression immediately following
radiation-induced myelosuppression42. Analysis of peripheral
blood in Tie2::IkB-SS mice revealed that endothelial-speciﬁc
NF-kB inhibition protected white blood cell, red blood cell
and total platelet loss following irradiation, with a rapid return to
pre-irradiation levels (Fig. 4b). The observation that Tie2::IkB-SS
mitigated peripheral haematopoietic damage following irradiation
suggests that NF-kB inhibition could also protect haematopoietic
tissues. To this end, we examined BM (femur) morphology
in control and Tie2::IkB-SS mice following irradiation.
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Haematoxylin and Eosin (H&E) staining revealed that
endothelial-speciﬁc NF-kB inhibition mitigated radiation-
induced BM cytopenia at early time points (Supplementary
Fig. 5; day 4), persisting throughout recovery. Because murine
haematopoietic cells and BM HSPCs are highly sensitive to
ionizing radiation43, we next examined BM haematopoietic
cellularity and total HSPCs in control and Tie2::IkB-SS mice
during active regeneration. Consistent with day 10 H&E staining
(Supplementary Fig. 5), Tie2::IkB-SS mice displayed a signiﬁcant
increase in total haematopoietic cellularity and in phenotypic
HSPCs per femur (Fig. 4c,d), suggesting a BM niche-mediated
haematopoietic protection. To determine if endothelial NF-kB
inhibition conferred a protective effect on other pro-
haematopoietic niche cells within the BM microenvironment,
we examined the diaphysis and trabecular regions of the BM
cavity following irradiation. To this end, we crossed mice
expressing GFP under the Col2.3 promoter44 with Tie2::IkB-SS
mice and analysed the BM microenvironment of Col2.3::GFP;
Tie2::IkB-SS and Col2.3::GFP littermate controls at day 10 post-
irradiation. Intravitally labelled endothelial cells (VECAD; red) in
Col2.3::GFP; Tie2::IkB-SS mice displayed maintenance of BM
integrity, including a preserved vascular network, morphology
and osteoblast/osteocyte architecture (green) when compared
with Col2.3::GFP control mice and steady state controls (Fig. 4e).
Haematopoietic cells were found in tightly associated cellular
packs within the BM parenchyma in Tie2::IkB-SS mice, whereas
the BM vasculature of control mice was tortuous and devoid of
dense haematopoietic cell clusters throughout the BM cavity
(Fig. 4e). To further examine radiation-mediated effects to the
femur morphology, we examined trabecular and cortical bone
using micro computed tomography (mCT). Bone volume relative
to total volume (BV/TV), trabecular and cortical bone thickness
was not signiﬁcantly altered in the femur of Tie2::IkB-SS
or littermate control mice at steady state or following
irradiation (Supplementary Fig. 6a,b). Interestingly, the
observed recovery in white blood cells and protection of vessel
morphology in Tie2::IkB-SS mice (Fig. 4b,e) is reﬂective of
the Tie2::IkB-SS/WT WBM reciprocal transplantations following
radiation-mediated myelosuppression (Fig. 3e,f), further demon-
strating that the haematopoietic radio-protective effect is niche-
mediated.
We next explored the possibility that the BM microenviron-
ment is protected in Tie2::IkB-SS mice following irradiation.
To this end, we assessed BM-niche constituents that modulate
HSC activity. Tie2::IkB-SS BM maintained pro-haematopoietic
citrullineþ megakaryocytes45 and LEPRþ perivascular niche
cells11,12 (Fig. 4f,h), while preventing PLIN1þ adipocyte
inﬁltration (Fig. 4g), which has been demonstrated to be a
negative regulator of haematopoiesis46. BM sinusoidal endo-
thelium undergo non-apoptotic cell death in response to ionizing
irradiation47, while reconstitution of haematopoiesis following
myelosuppressive insult is dependent on VEGFR2-mediated
regeneration of VEGFR3þ sinusoidal endothelial cell damage
in vivo8. Therefore, we set out to quantify BM VEGFR3þ
sinusoidal endothelial regression following radiation injury. WT
control mice displayed a marked increase in type I haemorrhagic/
discontinuous and type II regressed femoral vessels at day 4
following injury, with noticeable sinusoidal regeneration
beginning at day 14 (Fig. 4i,j). In stark contrast, Tie2::IkB-SS
mice strongly mitigated initial damage to the femoral vessels and
promoted more rapid recovery of VEGFR3þ sinusoids (Fig. 4i,j).
Moreover, preserved sinusoidal endothelium in Tie2::IkB-SS mice
was associated with a signiﬁcant increase in circulating
pro-haematopoietic granulocyte–macrophage CSF (GM-CSF)
levels (Supplementary Fig. 7a,b), suggesting a combinatorial
haematopoietic recovery.
To examine if the overall radio-protective effect of NF-kB
inhibition in endothelium was not limited to radiation injury,
Tie2::IkB-SS mice were administered a single myelosuppressive
dose of the chemotherapeutic agent 5-FU (150mg kg 1).
Tie2::IkB-SS mice displayed a rapid recovery of total white blood
cells when compared with littermate controls (Supplementary
Fig. 8a,b). Unlike radiation-mediated myelosuppression,
Tie2::IkB-SS mice displayed no distinct differences in total
haematopoietic or HSPC populations within the BM at day 10
post-5-FU (Supplementary Fig. 8c,d). However, Tie2::IkB-SS mice
did display a similar BM microenvironmental protection of vessel
morphology (Supplementary Fig. 8e), preservation of citrullineþ
megakaryocytes and LEPRþ niche constituents (Supplementary
Fig. 8f,h), while preventing the inﬁltration of PLIN1þ adipocytes
(Supplementary Fig. 8g). These data conﬁrm that NF-kB
inhibition in endothelial cells protects not only total haemato-
poietic cells and HSPCs in the BM following radiation injury, but
also maintains the vascular niche environment. Taken together,
endothelial-speciﬁc NF-kB inhibition in Tie2::IkB-SS mice
protects the haematopoietic compartment and the integrity of
the vascular niche, allowing for rapid recovery following
radiation- and chemotherapeutic-mediated suppressive damage.
IjB-SS BMEC infusion protects the BM niche following injury.
Transplantation of endothelial cells have been shown to mitigate
radiation-induced myeloablation, support HSPC recovery and
reduce the time of peripheral haematopoietic recovery in lieu
of a haematopoietic stem cell transplantation (HSCT)34,48–50.
Based on the data demonstrating that endogenous inhibition
of endothelial NF-kB signalling augments homeostatic and
regenerative haematopoiesis in vivo, we next sought to
determine if transplantation of NF-kB-inhibited BMECs can be
utilized as a cellular therapy to treat haematological disorders that
require radiation and/or chemotherapy to induce remission. To
this end, C57BL/6J recipients were injected with 5 105 cultured
WT control or Tie2::IkB-SS BMECs via retro-orbital sinus on four
successive days and assayed for haematopoietic recovery
following an LD50 dose of radiation (Fig. 5a). Although both
control and Tie2::IkB-SS BMECs transplantations mitigated
radiation-induced death (Fig. 5c), Tie2::IkB-SS BMECs resulted
in signiﬁcant enhancement of peripheral white blood cells,
red blood cells and platelets when compared with control
BMECs and PBS injected controls (Fig. 5b). While control
BMECs also promoted signiﬁcant haematopoietic recovery when
compared with PBS injected controls, NF-kB inhibition further
augmented the BMEC-mediated recovery with peripheral blood
counts rapidly normalizing to steady state controls (Fig. 5b). We
next sought to determine if NF-kB inhibition provided additional
HSPC radioprotection over BMEC controls. Transplanted
Tie2::IkB-SS BMECs preserved phenotypic HSCs at early time
points following irradiation and promoted accelerated HSC
recovery (Fig. 5d and Supplementary Fig. 9a,b). Accelerated
recovery of phenotypic HSCs was associated with an increase in
haematopoietic progenitor activity at day 5 post-irradiation,
normalizing by day 15 (Fig. 5e,f). The observed increase in HSPC
activity is reﬂective of early haematopoietic recovery noted in the
peripheral blood (Fig. 5b).
Similar to the observed haematopoietic recovery following
myelosuppression in Tie2::IkB-SS mice (Fig. 4b–d), Tie2::IkB-SS
BMEC transplanted mice demonstrate an acceleration in
peripheral blood recovery and mitigation of phenotypic and
functional HSPC attrition when compared with WT BMEC
transplantation or PBS injected controls (Fig. 5b–f). This raises
the possibility that Tie2::IkB-SS BMEC transplantation following
irradiation also protects the vascular niche by attenuating
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VEGFR3þ sinusoidal endothelial regression. To test this
possibility, we quantiﬁed VEGFR3þ BM sinusoidal endothelial
regression following BMEC transplantation. Mice transplanted
with WT BMECs demonstrated a modest, but signiﬁcant decrease
in Type I and Type II damaged BM sinusoidal vessels at day 5
post-irradiation when compared with PBS vehicle controls,
displaying a rapid haematopoietic and VEGFR3þ sinusoidal
recovery by day 10 (Fig. 5g,h). These data are consistent with the
pan-haematopoietic recovery previously described following
exogenous BMEC transplantation34 (Fig. 5b–f). However, mice
transplanted with Tie2::IkB-SS BMECs displayed a marked
protection of WBM cellularity and VEGFR3þ sinusoidal
vasculature as early as day 5 post-irradiation, when compared
with WT BMEC controls (Fig. 5g,h). The mitigation of BM
endothelial regression in Tie2::IkB-SS BMEC transplanted mice
was coupled with the rapid regeneration of any residual vascular
damage (Fig. 5g,h). Taken together, the intravenous delivery of
exogenous Tie2::IkB-SS BMECs following radiation-mediated
myeloablation in WT recipients protects the vascular niche in a
similar manner as endogenous NF-kB inhibition, allowing for the
possibility of transplanting tailored niche-speciﬁc endothelium as
a therapeutic modality in treatments that affect the vascular
niche.
IjB-SS BMEC infusion mitigates haematopoietic damage.
Based on these observations, we hypothesized that transplanta-
tion of Tie2::IkB-SS BMECs provides radioprotection of haema-
topoietic tissues, allowing for accelerated haematopoietic
recovery. To this end, we quantiﬁed reconstitution of leukocytes
in WBM, as this is a critical determinant of patient outcome
through the ability of leukocytes, particularly neutrophils to
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protect BM transplant recipients from opportunistic infections51–53.
Mice transplanted with Tie2::IkB-SS BMECs displayed signiﬁcantly
higher frequencies of neutrophils, monocytes, eosinophils and
macrophages at day 5 post-myeloablative irradiation (700 Rads),
when compared with WT BMEC and PBS injected controls
(Fig. 6a). Of note, neutrophil protection/recovery was distinct in the
Tie2::IkB-SS BMEC transplanted mice, with the frequency of
neutrophils being higher at days 5 and 10 post irradiation when
compared with non-irradiated steady state controls (Fig. 6a,b).
Histology of the trabecular region of the femur 10 days following
irradiation in Tie2::IkB-SS BMEC transplants demonstrated a
signiﬁcant radioprotection in terms of preserved marrow and
splenic cellularity when compared with WT BMECs and PBS
injected control mice (Fig. 6c). Tie2::IkB-SS BMEC transplantations
also displayed a signiﬁcant protective effect on the morphology of
the spleen following insult, which displayed normal architecture,
including localized red and white pulp (Fig. 6c). Taken together,
these data demonstrate that transplantation of exogenous Tie2::
IkB-SS BMECs results in a profound radio-protective effect
that can mitigate deleterious consequences associated with
total body irradiation and accelerate recovery of peripheral
haematopoietic cells.
Discussion
The NF-kB pathway orchestrates a diverse set of biological
functions, including cellular survival, proliferation and differ-
entiation, while the dysregulation of NF-kB signalling has been
implicated in the development of chronic inﬂammation, meta-
bolic disorders and emerging neoplasms. These properties have
made the NF-kB pathway an attractive therapeutic target for
haematopoietic disorders, including the treatment of cancer and
autoimmune disease54–57. In endothelial cells, the activation
of pro-inﬂammatory NF-kB signalling in response to viral and
bacterial infections can drive HSPC proliferation and
differentiation in order to supplement the cellular immune
response21,22. However, chronic inﬂammatory signalling has been
shown to result in impairment of HSC repopulation
potential17,27,30, while chronic activation of NF-kB signalling in
the BM vascular niche can promote a myeloproliferative-like
disorder through the expression of pro-inﬂammatory cytokines30.
In addition, pre-conditioning regimens for HSCT to treat
haematological malignancies and autoimmune disorders can
cause systemic endothelial damage and have been implicated in
the progression of HSCT-related life-threatening complications
through endothelial apoptosis and pro-inﬂammatory cytokine
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production58,59. Therefore, strategies aimed at limiting pro-
inﬂammatory responses that effect HSC maintenance and BM
endothelial niche integrity may be an attractive option to preserve
long-term HSC function following haematopoietic injury.
In this study, we identify the canonical NF-kB pathway as an
extrinsic mediator of HSC function within the adult BM
endothelial niche. Endothelial-speciﬁc inhibition of canonical
NF-kB signalling using a dominant negative IkB-SS construct
expressed under Tie2 promoter elements has identiﬁed NF-kB as
a key regulator within BM endothelial cells that is capable of
modulating the size, cell cycle status and functionality of the HSC
pool during homeostasis (Fig. 6d). NF-kB-speciﬁc inhibition in
BM endothelium also promotes rapid haematopoietic recovery
following chemo- and radiation-induced myelosuppression.
Moreover, Tie2::IkB-SS mice safeguard the pro-haematopoietic
BM microenvironment by preventing VEGFR3þ sinusoidal
endothelial cell regression and suppressing the inﬁltration
of adipocytes, negative regulators of haematopoiesis, following
injury. Preservation of the sinusoidal BM vascular niche in
Tie2::IkB-SS mice suggests that the activation of canonical NF-kB
signalling following ionizing radiation promotes endothelial
apoptosis in vivo. Indeed, numerous reports have identiﬁed
endothelial cells as susceptible to irradiation- and TNFa-
mediated cell death, establishing NF-kB signalling as a potential
axis regulating endothelial survival following radiation-mediated
myeloablation60,61. TNFa is rapidly and transiently expressed in
the BM microenvironment following total body irradiation and
promotes WBM cell apoptosis. Accordingly, TNFa knockout
mice display a decrease in haematopoietic cell death and an
increase in BM cellularity following acute radiation42.
Considering the BM vascular niche is essential for the
reconstitution of haematopoiesis following chemotherapeutic
and radiation-induced insult, preserving the integrity of the
BM microenvironment, particularly the endothelial niche, may
provide a therapeutic opportunity to augment current HSCT
approaches to increase haematopoietic engraftment and promote
more rapid recovery of haematopoietic tissues following
pre-conditioning regimens.
Because NF-kB signalling has been shown to promote
the expression of pro-inﬂammatory cytokines, we analysed
circulating cytokine concentrations in Tie2::IkB-SS mice follow-
ing radiation-induced myelosuppression, identifying signiﬁcant
changes in M-CSF, IL6 and GM-CSF62–64 (Supplementary
Fig. 7b). The observed decrease in plasma concentrations of
M-CSF and IL6 coincide with the suppression NF-kB signalling
in endothelium following irradiation. M-CSF and IL6 can directly
promote HSPC myeloid differentiation26,27; therefore, it is
plausible that the systemic downregulation of these cytokines
preserves HSC functionality at the expense of differentiation.
Interestingly, GM-CSF plasma levels are increased in Tie2::IkB-SS
mice following radiation (Supplementary Fig. 7b). The
administration of GM-CSF following chemotherapy in patients
has been shown to increase survival, reducing the severity of
neutropenia and treatment-related infections, and enhance
overall haematopoietic recovery following HSCT65. Because
GM-CSF gene expression can be induced by canonical NF-kB,
the observed increase in plasma GM-CSF levels may be an
indirect effect of NF-kB inhibition in endothelium. Nonetheless,
increased GM-CSF levels may be at least partially responsible for
promoting rapid haematopoietic regeneration following total
body irradiation in Tie2::IkB-SS mice.
In this manuscript, we modulate NF-kB function within the
BM microenvironment in vivo utilizing a Tie2 promoter-driven
IkB-SS transgenic mouse model that speciﬁcally inhibits canoni-
cal NF-kB activation in endothelial cells39. However, endogenous
Tie2 expression has been reported on phenotypic side population
cells (HSCs), in association with its ligand Angiopoietin-1 in the
BM osteoblastic niche41. Therefore, conﬁrming the lineage-
restricted expression of the dominant-negative IkB-SS transgene
to the microenvironment in this report is paramount to our
conclusions. Common Tie2 core promoter/enhancer elements
used to faithfully drive endothelial-speciﬁc transgene expression
in multiple murine models have demonstrated that NF-kB
inhibition and cre-mediated deletion of target genes is limited to
endothelial cells30,32,66,67. Nonetheless, to rule out off-target
expression of the Tie2::IkB-SS transgene, we examined both
TIE2 expression and NF-kB functionality in phenotypic
HSCs. Using the same TIE2 antibody clone described in Arai
et al.41 cKITþLineageSCA1þCD150þCD48 HSCs from
both Tie2::IkB-SS and littermate control mice displayed
scant TIE2 staining by ﬂow cytometry and intact canonical NF-
kB activity in response to TNFa-stimulation, while freshly
isolated TIE2þVECADþCD31þCD45 BM endothelium
from Tie2::IkB-SS mice were functionally unresponsive to
TNFa (Fig. 3a,b). Cell-autonomous canonical NF-kB signalling
is critical for HSC maintenance; IkBa-dependent RelA/p65
knockout mice using either haematopoietic speciﬁc Vav1-cre or
Mx1-cre in BM niche-independent reciprocal transplants
demonstrated a twofold decrease in phenotypic
cKITþLineageSCA1þCD150þCD48 HSCs, a 17-fold
decrease in competitive repopulating cells, and an increase in
HSC cell cycling68, in contrast to the increase in quiescent, long-
term repopulating HSCs in Tie2::IkB-SS mice (Fig. 2d–i). These
data verify the functional absence of IkB-SS-mediated NF-kB
inhibition in Tie2::IkB-SS HSCs. Moreover, WT-derived WBM
transplanted into irradiated Tie2::IkB-SS recipients displayed an
increase in haematopoietic cellularity and HSC frequency in
the femur at four months following reconstitution (Fig. 3c,d)
reﬂective of steady state Tie2::IkB-SS mice (Fig. 2a,d), conﬁrming
a microenvironmental role of NF-kB inhibition.
Myelosuppressive total body irradiation of established reciprocal
transplanted mice also demonstrated a signiﬁcant increase in the
recovery of peripheral white blood cells and protection of the
vasculature (Fig. 3e,f), similar to endogenous recovery in
Tie2::IkB-SS mice (Fig. 4b,e). To further rule out Tie2::IkB-SS
expression in the HSC compartment, we conducted experiments
using WT HSCs. WT-derived HSCs used in our ex vivo BMEC
co-culture platform and endogenous WT HSCs in our in vivo
BMEC transplantation assay demonstrate the preferential
expansion of long-term repopulating HSCs and protection of
the BM vascular niche and haematopoietic tissues following
radiation-mediated myeloablation, respectively. These results
clearly demonstrate that the observed niche-mediated HSC
phenotype is due to endothelial-speciﬁc NF-kB inhibition
(Fig. 1, Supplementary Figs 4–6). Taken together, the inhibition
of endothelial-speciﬁc NF-kB signalling in Tie2::IkB-SS mice
promotes an increase in long-term repopulating HSCs during
homeostasis, while mitigating pan-haematopoietic damage in
response to chemo- and radiation-induced myelosuppression.
The observed enhanced haematopoietic recovery is accompanied
by preservation of the BM microenvironment, including
the protection of vascular niche, and an increase in circulating
GM-CSF.
The use of our ex vivo BMEC expansion platform to identify
NF-kB signalling as a key regulatory pathway in the BM vascular
niche has unlocked the potential for a cellular therapy approach
to treat haematopoietic disease requiring cytotoxic regimens.
Given that a delay in neutrophil and platelet engraftment is a
major cause of morbidity/mortality and prolonged hospitalization
following cord blood HSC transplantations51–53, the observation
that Tie2::IkB-SS BMEC transplantation recipients maintain
neutrophil counts and comparable platelet levels following an
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LD50 myeloablative dose of radiation, suggests that the co-
infusion of genetically modiﬁed vascular cells could be utilized as
an adjuvant cellular therapy in conjunction with HSC transplants
to enhance the engraftment of HSPCs, as well as decrease the
morbidity and mortality associated with radiation/chemotherapy
induced pancytopenias.
Methods
Animal use. All animal experiments were performed under the approval of Weill
Cornell Medical College and the Institutional Animal Care and Use Committee.
C57BL/6J (CD45.2), B6.SJL-PtprcaPepcb/BoyJ (CD45.1) and B6.Cg-Tg(Col1a1*2.3-
GFP)Rowe/J (Col2.3::GFP) mice were purchased from The Jackson Laboratory.
BAC transgenic Tie2::IkB-SS mice were obtained from Jan Kitajewski39 at
Columbia University and maintained on a C57BL/6J (CD45.2) background.
All experiments were conducted using Tie2::IkB-SS and Col2.3::GFP hemizygous
mice with the appropriate littermate negative controls. Mice were maintained in
speciﬁc-pathogen-free housing and used at 12–16 weeks of age for all experiments.
Tie2::IkB-SS and WT littermate control mice were not segregated based on sex for
described experiments. For haematopoietic recovery, reconstitution and BMEC
transplantation studies, mice were subjected to total body g-irradiation (137Cs) 24 h
before transplantation at indicated doses. Transplant recipients were given PicoLab
Mouse 20 antibiotic feed (0.025% Trimethoprim and 0.124% Sulfamethoxazole;
LabDiet) 24 h before irradiation until 28 days post-transplant.
Lentivirus. The IkB-SS transgene was ampliﬁed using PCR Extender System
(5Prime) from the pBabe-GFP-IkBa-mut vector36 (AddGene; plasmid#15264) with
forward 50-aggatccgccaccatgttccaggcggccgag-30 and reverse primers 50-
agtcgactcataacgtcagacgctggcct-30 containing BamHI and SalI sites and cloned into
the Topo pCR2.1 vector (Life Technologies). The resulting pCR2.1-IkB-SS vector
was digested with BamHI and SalI (New England Biolabs) and subcloned into
the pCCL vector69. pCCL-myrAkt13 and pCCL-IkB-SS virus was generated by
transfecting 13mg of lentiviral backbone with 5 mg RRE, 2.5 mg REV and 3 mg
VSV packaging plasmids into a 10 cm plate of 80% conﬂuent 293T/17 cells
(American Type Culture Collection) using Lipofectamine 2000 (Life Technologies)
according to the manufacturer’s suggestions. Supernatants were collected 48 h
post-transfection, concentrated using Lenti-X Concentrator (ClonTech) according
to the manufacturer’s recommendations, resuspended in 0.5ml TNE Buffer
(50mM Tris, pH 8.0, 1mM EDTA, 130mM NaCl and stored at  80 C. Viral
titer was determined using Lenti-X p24 Rapid Titer Kit (ClonTech). All
transductions were done using approximately 10,000 pg virus per 30,000
BMECs cm 1.
BMEC isolation. Primary murine BMECs were isolated from Tie2::IkB-SS or
WT littermates and transduced with a constitutively-active myristoylated Akt1-
expressing lentivirus to promote survival in serum- and cytokine-free conditions.
To generate BMEC cultures, femur, tibia and humerus bones were isolated,
denuded of excess tissue, crushed using a mortar and pestle and enzymatically
disassociated in Hanks Balanced Salt Solution (Life Technologies) containing
20mM HEPES (CellGro), 2.5mgml 1 Collagenase A (Roche), and 1 Unit ml 1
Dispase II (Roche) for 15min at 37 C with gentle agitation. Resulting cell sus-
pensions were passed through a 40 mm ﬁlter, washed in PBS (pH 7.2) containing
0.5% BSA (Fraction V) and 2mM EDTA, and depleted of terminally differentiated
haematopoietic cells using a Lineage Cell Depletion Kit (Miltenyi Biotec) according
to the manufacturer’s suggestions. BMECs were immunopuriﬁed from resulting
cell suspensions using Dynabeads (Life Technologies) pre-captured with a
monoclonal CD31 antibody (MEC13.3; Biolegend). In short, 10 ml of sheep anti-rat
IgG Dynabeads were incubated with 1 mg of CD31 antibody (per isolation) for
30min at 4 C, washed three times, added to lineage-depleted WBM in a ﬁnal
volume of 1ml, and incubated for 30min at 4 C. Resulting CD31þ cells were
plated and grown on ﬁbronectin-coated (Sigma-Aldrich) plates. Antibody capture,
cell isolation, and washes were done in PBS (pH 7.2) containing 0.5% BSA
(Fraction V) and 2mM EDTA. Dynabead-CD31 capture, BMEC isolations, and
washes were done using a DynaMag-2 magnet (Life Technologies). C57BL/6J and
Tie2::IkB-SS BMECs were cultured in low glucose DMEM (Life Technologies) and
Ham’s F-12 (CellGro) (1:1 ratio), supplemented with 20% heat-inactivated FBS,
antibiotic-antimycotic (CellGro), non-essential amino acids (CellGro), 10mM
HEPES (CellGro), 100 mgml 1 heparin (Sigma-Aldrich) and 50 mgml 1 endo-
thelial mitogen (Biomedical Technologies, Inc). To select for Akt1-expressing
BMECs, cultures were starved for seven days in serum- and cytokine-free Stem-
Span SFEM (StemCell Technologies, Inc.) media. All BMEC lines were subse-
quently sorted for VECADþ (BV13; Biolegend), CD31þ (390; Biolegend),
CD45 (30-F11; Biolegend) populations to ensure purity. To generate IkB-SS
expressing endothelial cells from WT C57BL/6J endothelium, Akt1-BMECs were
transduced with IkB-SS expressing lentivirus. All experiments were done using
heterogeneous pCCL-myrAkt/pCCL-IkB-SS-transduced BMEC lines. Cells were
cultured in humidiﬁed incubators at 37 C under 5% CO2.
IjB-SS-BMEC functional analysis. To conﬁrm IkB-SS transduction efﬁciency and
NF-kB pathway activation, IkB-SS-BMECs were serum-starved overnight in
X-Vivo 20 (Lonza) media, activated by the addition of recombinant murine TNFa
(PeproTech) at 20 ngml 1 for 15min, ﬁxed/permeabilized, and stained using the
following antibodies and dilutions: IkBa at 1:400 (L35A5; Cell Signaling) and
secondary goat anti-rabbit Alexa Fluor 488 at 1:200 (Life Technologies), GM-CSF
at 1:100 (MP1-22E9; Biolegend), IL6 at 1:100 (MP5-20F3; Biolegend), IL3 at 1:100
(MP2-8F8; Biolegend), IFNg at 1:100 (XMG1.2; Biolegend), CD40 at 1:100 (3/23;
BD Bioscience), or CD40L at 1:100 (gp39; BD Bioscience). Non-activated (No
TNFa) and non-transduced BMECs served as controls. Cells were analysed using
ﬂow cytometry.
For immunocytochemical analysis, IkB-SS-transduced BMECs were grown on
ﬁbronectin-coated (Sigma-Aldrich) glass chamber slides (Lab-Tek) at a density of
3 104 cells 0.7 cm 2, serum-starved overnight in X-Vivo 20 (Lonza) media, and
activated with the addition of recombinant murine TNFa (PeproTech) at
20 ngml 1 for 15min. Following, NF-kB activation, cells were brieﬂy washed with
ice-cold PBS (pH 7.2) and ﬁxed in 4% paraformaldehyde (PFA) in PBS (pH 7.2) for
10min at room temperature, washed 3 5min in PBS (pH 7.2), permeabilized and
blocked in 5% normal goat serum (Jackson ImmunoResearch Laboratories, Inc),
1% Triton X-100, and aCD16/32 at 1:50 (93; Biolegend) in PBS (pH 7.2) for
30min, and stained with a p65-speciﬁc antibody at 1:100 (C22B4; Cell Signaling)
in 1% BSA (Fraction V), 1% Triton X-100 in PBS (pH 7.2) for 1 h at room
temperature. Sections were washed 3 5min in PBS (pH 7.2) and incubated in 1%
BSA (Fraction V), 1% Triton X-100 in PBS (pH 7.2) with goat anti-rat Alexa Fluor
647 at 1:250 (Life Technologies) for 30min at room temperature. All tissues were
counterstained with 4,6-diamidino-2-phenylindole (DAPI) at 1 mgml 1 and
mounted using Prolong Gold anti-fade solution (Life Technologies). Cells were
imaged on a LSM 710 confocal microscope (Zeiss).
To determine non-canonical NF-kB activation status in IkB-SS-transduced
BMECs, cells were serum-starved overnight in X-Vivo 20 (Lonza) media, and
NF-kB activated with the addition of recombinant murine TNFa (PeproTech) at
20 ngml 1 for 15min. Following, NF-kB activation, cells were brieﬂy washed with
ice-cold PBS (pH 7.2) and lysed in RIPA buffer (150mM NaCl, 1% IGEPAL CA-
630, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate (SDS), and 50mM Tris-HCl,
pH 8.0) with working concentrations of PhosStop Phosphatase Inhibitor (Roche)
and Complete EDTA-free Protease Inhibitor Cocktail (Roche) for 20min at 4 C,
sonicated, and centrifuged for 10min at 21,000 g at 4 C. Supernatants were stored
at  80 C. Protein concentrations were determined using the DC Protein Assay
(BioRad) and 5 mg total protein was resolved on 8% SDS–acrylamide gels and
electroblotted to nitrocellulose. Transferred blots were blocked for 1 h in 5% non-
fat dry milk in PBS (pH 7.2) with 0.05% IGEPAL CA-630 and incubated overnight
at 4 C in 5% non-fat dry milk in PBS (pH 7.2) with 0.05% IGEPAL CA-630 with
primary antibodies raised against NF-kB2 at 1:1,000 (p100/p52) (4882; Cell
Signaling), JAGGED-1 at 1:1,000 (28H8; Cell Signaling), or b-tubulin at 1:1,000
(2146; Cell Signaling). Blots were washed 3 10min in PBS (pH 7.2) with 0.05%
IGEPAL CA-630 at room temperature and incubated in 5% non-fat dry milk in
PBS (pH 7.2) with 0.05% IGEPAL CA-630 and anti-rabbit IgG (Hþ L) horseradish
peroxidase (Jackson ImmunoResearch Laboratories, Inc) secondary antibodies at a
1:5,000 dilution for 1 h at room temperature. Blots were washed 3 10min in PBS
(pH 7.2) with 0.05% IGEPAL CA-630 at room temperature and developed using
Amersham ECL Prime Western Blotting Detection Reagent, according to the
manufacturer’s suggestions. All blots were developed using Carestream Kodak
BioMax Light Film (Sigma-Aldrich). All uncropped western blots can be found in
Supplementary Fig. 10.
BMEC-HSPC co-culture. Primary murine HSPCs were co-cultured on AKT-
activated or AKT-activated/NF-B-inhibited BMEC feeders in serum-free condi-
tions with sKITL supplementation. To establish co-cultures, femurs and tibia from
C57BL/6J (CD45.2þ ) mice were isolated and WBM was ﬂushed using a 26.5 gauge
needle with PBS (pH 7.2) containing 0.5% BSA (Fraction V) and 2mM EDTA.
WBM was depleted of lineageþ cells using a Lineage Cell Depletion Kit (Miltenyi
Biotec), stained using antibodies raised against cKIT at 1:100 (2B8; Biolegend) and
SCA1 at 1:100 (D7; Biolegend), and sorted for KLS populations. Resulting KLS
(2,500 cells per well) were plated on a single well of a 12-well dish, pre-plated with
BMECs as feeders, in StemSpan SFEM serum-free media (StemCell Technologies,
Inc.) with 50 ngml 1 recombinant murine sKITL (PeproTech). Note: Individual
BMEC wells were washed three times with PBS (pH 7.2) before plating/splitting to
remove any residual EC growth media. To test each individually isolated WT or
IkB-SS-transduced/Tie2::IkB-SS-derived BMEC line (n¼ 3), three independent
KLS populations were used in parallel for each individual co-culture experiment.
Cells were co-cultured at 37 C and 5% CO2 for nine days and split as follows:
(day 2) Co-cultures were supplemented with 50 ngml 1 sKITL; (day 4) co-cul-
tures were supplemented with 0.5mls StemSpan SFEM and 50 ngml 1 sKITL;
(day 6) non-adherent haematopoietic cells were collected, centrifuged at 500 g for
5min, pellets were resuspended in 3mls StemSpan SFEM, and 1.5mls were plated
onto the original and adjacent 12-well with BMECs (1:2 split) and supplemented
with 50 ngml 1 sKITL; (day 8) co-cultures were split 1:2 by transferring 0.75ml of
non-adherent haematopoietic cells onto adjacent 12-wells (total 4 12-wells per
expansion), adding back 0.75mls StemSpan SFEM to the original wells (1.5mls
total culture volume per 12-well), and supplementing with 50 ngml 1 sKITL;
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13829 ARTICLE
NATURE COMMUNICATIONS | 7:13829 | DOI: 10.1038/ncomms13829 |www.nature.com/naturecommunications 11
(day 9) BMECs and total haematopoietic cells were collected using Accutase
(Biolegend) and analysed. Total cell numbers were determined using haemocyt-
ometer counts with Trypan Blue (Life Technologies) for live/dead exclusion.
Lineage haematopoietic cell composition following co-culture was assessed using
the following antibodies and dilutions: GR1 at 1:100 (RB6-8C5; Biolegend), CD11B
at 1:100 (M1/70; Biolegend), B220 at 1:100 (RA3-6B2; Biolegend), CD3 at 1:50
(17A2; Biolegend), CD41 at 1:100 (MWReg30; Biolegend) and CD45 at 1:100
(30-F11; Biolegend). Lineageþ haematopoietic cell composition following co-cul-
ture was assessed using the following antibodies and dilutions: GR1 at 1:100 (RB6-
8C5; Biolegend), CD11B at 1:100 (M1/70; Biolegend), CD41 at 1:100 (MWReg30;
Biolegend), and CD45 at 1:100 (30-F11; Biolegend). To assess HSC activity, total
co-culture cells were stained with an antibody raised against CD45.2 at 1:100
(104; Biolegend), sorted to purity, and 105 CD45.2þ expansion cells were trans-
planted into lethally-irradiated CD45.1 recipients (950 Rads) with 5 105
CD45.1þ competitive WBM (per mouse) via retro-orbital injection. For secondary
analysis, WBM cells were isolated from primary recipients 16 weeks post-trans-
plantation and 106 total WBM cells were transplanted into lethally-irradiated
(950 Rads) CD45.1þ recipients (per mouse) via retro-orbital injection, as described
above. Multi-lineage engraftment in peripheral blood was assayed four months-
post transplant. For endothelial NF-kB pre-activation, BMECs were serum-starved
overnight followed by the addition of 10 ngml 1 recombinant murine TNFa for
20min. Following NF-kB endothelial activation, wells were washed three times
with PBS (pH 7.2) to remove residual TNFa and HSPCs were then plated.
Flow cytometry and cell sorting. Before staining, Fc receptors were blocked with
a CD16/32 antibody at 1:50 (93; Biolegend) in PBS (pH 7.2) containing 0.5% BSA
(Fraction V) and 2mM EDTA for 10min at 4 C. For cell surface staining, samples
were stained for 30min at 4 C with ﬂuorochrome-conjugated antibodies according
to the manufacturer’s recommendation. Stained cells were washed in blocking
buffer and ﬁxed in 1% PFA in PBS (pH 7.2) with 2mM EDTA for ﬂow analysis or
resuspended in PBS (pH 7.2) with 2mM EDTA and 1 mgml 1 DAPI (Biolegend)
for sorting. For intracellular staining, cells were processed with BD Phosﬂow
Fix Buffer I (BD Bioscience) and BD Phosﬂow Perm Buffer III (BD Bioscience)
according to the manufacturer’s suggestions and stained with primary ﬂuor-
ochrome-conjugated antibodies as described. Samples were analysed using a LSR II
SORP (BD Biosciences) and sorted using an ARIA II SORP (BD Biosciences). Data
was collected and analysed using FACs DIVA 8.0.1 software (BD Biosciences).
All gating was determined using unstained controls and ﬂuorescence minus one
strategies.
WBM analysis. To quantify total BM haematopoietic cell counts at steady state
and during recovery, femurs were isolated, denuded of excess tissue, crushed using
a mortar and pestle and enzymatically disassociated in Hanks Balanced Salt
Solution (Life Technologies) containing 20mM HEPES (CellGro), 2.5mgml 1
Collagenase A (Roche), and 1 Unitml 1 Dispase II (Roche) for 15min at 37 C
with gentle agitation. Resulting cell suspensions were passed through a 40 mm ﬁlter
and washed in PBS (pH 7.2) containing 0.5% BSA (Fraction V) and 2mM EDTA.
Total cell numbers were determined using haemocytometer counts with Trypan
Blue (Life Technologies) for live/dead exclusion. To assess haematopoietic popu-
lations, WBM was isolated from femurs crushed with a mortar and pestle in PBS
(pH 7.2) containing 0.5% BSA (Fraction V) and 2mM EDTA, and stained for
phenotypic resident HSC, HSPC and myeloid cell surface markers using the fol-
lowing antibodies and dilutions: HSC/HSPC; cKIT at 1:100 (2B8; Biolegend), SCA1
at 1:100 (D7; Biolegend), CD150 at 1:100 (TC15-12F12.2; Biolegend), CD48 at
1:100 (HM48-1; Biolegend) and lineageþ GR1 at 1:100 (RB6-8C5; Biolegend),
CD11B at 1:100 (M1/70; Biolegend), B220 at 1:100 (RA3-6B2; Biolegend), CD3
at 1:50 (17A2; Biolegend), CD41 at 1:100 (MWReg30; Biolegend), TER119 at 1:100
(TER119; Biolegend), and myeloid; GR1 at 1:100 (RB6-8C5; Biolegend), CD115 at
1:100 (AFS98; Biolegend), F4/80 at 1:100 (BM8; Biolegend). Samples were analysed
using ﬂow cytometry.
Peripheral blood. Peripheral blood was collected using 75mm heparinized glass
capillary tubes (Kimble-Chase) via retro-orbital sinus at indicated time points. To
assess haematopoietic recovery following myeloablation, white blood cell, red blood
cell and platelet populations were analysed using an Advia120 (Bayer Healthcare).
To quantify lineageþ haematopoietic cells and HSC engraftment, peripheral blood
was depleted of red blood cells (RBC lysis; Biolegend), stained with pre-conjugated
antibodies and analysed using ﬂow cytometry. Antibodies and dilutions used for
lineageþ haematopoietic cell analysis: GR1 at 1:100 (RB6-8C5; Biolegend), CD11B
at 1:100 (M1/70; Biolegend), B220 at 1:100 (RA3-6B2; Biolegend), CD3 at 1:50
(17A2; Biolegend), at 1:100 CD4 (GK1.5; Biolegend), and CD8 at 1:100 (53-6.7;
Biolegend). Antibodies used for haematopoietic engraftment: CD45.1 at 1:100
(A20; Biolegend), CD45.2 at 1:100 (104; Biolegend), TER119 at 1:100 (TER119;
Biolegend).
Progenitor activity. Haematopoietic progenitor activity was assessed by quanti-
fying CFUs in semi-solid methylcellulose. For in vivo analysis, WBM was ﬂushed
from isolated femurs using a 26.5 gauge needle with PBS (pH 7.2) containing 0.5%
BSA (Fraction V) and 2mM EDTA at indicated time points, counted using a
haemocytometer with Trypan Blue (Life Technologies) for live/dead exclusion,
and plated (in duplicate) in Methocult GF M3434 methylcellulose (StemCell
Technologies) according to the manufacturer’s protocol. For ex vivo expansion
analysis, total haematopoietic cells were stained with anti-CD45 at 1:100 (30-F11;
Biolegend), sorted, and plated as described above. Colonies were viewed using a
SZX16 Stereo-Microscope (Olympus) and scored for phenotypic CFU-GEMM,
CFU-GM, CFU-G, CFU-M and BFU-E colonies.
Cell cycle. Cell cycle analysis was performed on phenotypically deﬁned in vivo
steady state HSCs (cKITþLineageSCA1þCD150þCD48 ) and expanded
ex vivo HSPCs (CD45þ cKITþLineageSCA1þ ) using the following ﬂuorescently
conjugated antibodies and dilutions: cKIT at 1:100 (2B8; Biolegend), SCA1 at 1:100
(D7; Biolegend), CD150 at 1:100 (TC15-12F12.2; Biolegend), CD48 at 1:100
(HM48-1; Biolegend) and lineageþ GR1 at 1:100 (RB6-8C5; Biolegend), CD11B at
1:100 (M1/70; Biolegend), B220 at 1:100 (RA3-6B2; Biolegend), CD3 at 1:50 (17A2;
Biolegend), CD41 at 1:100 (MWReg30; Biolegend), TER119 at 1:100 (TER119;
Biolegend) and CD45 at 1:100 (30-F11; Biolegend). In short, ﬂushed WBM or total
BMEC-HSPC co-cultures were stained for HSC or HSPC surface markers, as
described above. Cells were then ﬁxed/permeabilized and stained with an antibody
raised against Ki67 (16A8; Biolegend) and counterstained with Hoechst 33342 (BD
Biosciences), according to the manufacturer’s recommendations. Samples were
analysed using ﬂow cytometry.
Limiting dilution. To isolate HSPCs, femurs and tibiae were harvested from
Tie2::IkB-SS mice and littermate controls (CD45.2þ ), ﬂushed using a 26.5 gauge
needle with PBS (pH 7.2) containing 0.5% BSA (Fraction V) and 2mM EDTA to
recover WBM, and depleted of lineageþ haematopoietic cells using the murine
Lineage Cell Depletion Kit (Miltenyi Biotec) according to the manufacturer’s
suggestions. Phenotypically deﬁned HSPCs (cKITþSCA1þ ) were stained and live
cells (DAPI ) were sorted from resulting lineage-depleted WBM for competitive
transplantation. For limiting dilution analysis, indicated numbers of HSPC (KLS)
were transplanted into lethally irradiated CD45.1 recipients (950 Rads) with
5 105 CD45.1þ competitive WBM (per mouse) via retro-orbital injection.
Percent negative mice were determined six months post-transplant by assessing the
contribution of CD45.2þ haematopoietic engraftment in the peripheral blood, as
described above. Transplanted mice displaying o1% CD45.2þ contribution were
qualiﬁed as negative engraftment. HSC frequency and 95% conﬁdence intervals
were determined using ELDA software (http://bioinf.wehi.edu.au/software/elda/)70.
HSC self-renewal. Tie2::IkB-SS mice and littermate controls were subjected to
weekly administration of the chemotherapeutic drug 5-ﬂuorouracil (5-FU;
150mg kg 1) (Sigma-Aldrich) via intraperitoneal injection. Mice were monitored
daily for moribundity and survival daily.
In vivo Tie2::IjB-SS expression. Tie2::IkB-SS and littermate control mice were
intravitally labelled for 10min with 25 mg Alexa Fluor 647-conjugated VECAD
antibody (BV13; Biolegend) via retro-orbital sinus injection, mice were killed and
perfused via intracardiac injection with PBS (pH 7.2). Femurs and tibiae were
harvested and crushed using a mortar and pestle and enzymatically digested in
Hanks Balanced Salt Solution (Life Technologies) containing 10mM HEPES
(pH 7.2) (CellGro) and 2.5mgml 1 Collagenase A (Roche) and 1 unit ml 1
Dispase II (Roche) for 15min at 37 C with gentle agitation. Subsequent cell sus-
pensions were washed using PBS (pH 7.2) containing 0.5% BSA (Fraction V) and
2mM EDTA and depleted of lineageþ haematopoietic cells using a Lineage Cell
Depletion Kit (Miltenyi Biotec), according to the manufacturer’s suggestions.
To assess Tie2 expression, lineage-depleted WBM was stained for phenotypic
HSC and BMEC surface markers using the following antibodies and dilutions:
HSCs; cKIT at 1:100 (2B8; Biolegend), SCA1 at 1:100 (D7; Biolegend), CD150
at 1:100 (TC15-12F12.2; Biolegend), CD48 at 1:100 (HM48-1; Biolegend) and
BMECs; CD31 at 1:100 (390; Biolegend). Resulting cells were washed, ﬁxed/
permeabilized and stained with an antibody raised against TIE2 at 1:20 (TEK4;
Biolegend).
To assess NF-kB activation potential, lineage-depleted WBM was incubated
with 20 ngml 1 of murine recombinant TNFa (PeproTech) in X-Vivo 20 (Lonza)
media for 20min at 37 C and stained for phenotypic HSC and BMEC surface
markers as described above. Resulting cells were washed, ﬁxed/permeabilized and
stained with a primary antibody raised against phosphorylated p65 at 1:1,000
(93H1; Cell Signaling), and secondary antibody goat anti-rabbit Alexa Fluor 488
at 1:250 (Life Technologies), according to the manufacturer’s recommendations.
Isotype controls were used to establish signalling baselines. Samples were analysed
using ﬂow cytometry.
Reciprocal transplantation. Long-bones from Tie2::IkB-SS or littermate control
mice were isolated and WBM was ﬂushed using a 26.5 gauge needle with PBS
(pH 7.2) containing 0.5% BSA (Fraction V) and 2mM EDTA. 106 WBM cells in
PBS (pH 7.2) were transplanted into lethally irradiated (950 Rads) reciprocal
recipients (per mouse) and assayed 16 weeks post-transplant for total
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haematopoietic cells per femur, HSCs per femur and haematopoietic recovery
following myelosuppression.
In vivo histology and immunohistochemistry. Histologic analysis for control and
Tie2::IkB-SS mice following 650 Rads of total body irradiation or control and
Tie2::IkB-SS BMEC transplantation following 700 Rads of total body irradiation
was performed by Histoserv, Inc (Germantown, MD). In short, killed mice were
perfused with PBS (pH 7.2) via intracardiac injection, tissues were ﬁxed in 4% PFA
in PBS (pH 7.2) overnight at 4 C, decalciﬁed for 72 h in 10% EDTA at room
temperature and dehydrated in 70% ethanol. Parafﬁn embedded sections (6 mm)
were stained with H&E. BM and spleen images were taken on a BX51 (Olympus)
light microscope at 10 and 20 magniﬁcation, respectively.
To analyse VEGFR3þ BM sinusoidal regression, parafﬁn embedded sections
(6mm; Histoserv, Inc) from Tie2::IkB-SS mice following 650 Rads of total body
irradiation or control and Tie2::IkB-SS BMEC transplantation following 700 Rads
of total body irradiation were deparafﬁnized in Xylene (VWR) and rehydrated
through serial ethanol washes as follows: Xylene 2 3min; 100% ethanol
2 3min; 95% ethanol 1 3min; 80% ethanol 1 3min; 70% ethanol 1 3min;
50% ethanol 1 3min and water rinse. Antigens were retrieved by incubating
rehydrated sections in 10mM sodium citrate and 0.05% Tween-20 at 95 C-100 C
for 20min. Sections were quenched for peroxidase activity with 0.3% H2O2 for
30min at room temperature, antigen blocked with 2.5% Normal Goat Serum
(ImmPRESS Kit; Vector Laboratories), and incubated with either a VEGFR3
antibody (AFL4; Biolegend) at 20 mgml 1 or IgG isotype control antibody
(HTK888; Biolegend) at 20 mgml 1 overnight at 4 C in Normal Goat Serum,
according to the manufacturer’s suggestions. Stained sections were washed,
incubated in ImmPRESS Reagent (Vector Laboratories), and developed using
ImmPACT DAB peroxidase substrate (Vector Laboratories), according to the
manufacturer’s protocol. Sections were washed for 10min in water and
counterstained in Mayer’s Haematoxylin Solution (Sigma) for 6min, and cleared
through serial dehydration with ethanol and xylene as follows: 70% ethanol
1 3min; 95% ethanol 1 3min; 100% ethanol 2 3min; Xylene 2 3min.
Sections were mounted using DPX Mountant medium (Sigma). Images were
taken on a BX51 (Olympus) light microscope at 20 magniﬁcation.
For immunohistochemical analysis, Tie2::IkB-SS, Col2.3-GFP and WT control
mice were intravitally labelled for 10min with 25 mg Alexa Fluor 647-conjugated
VECAD antibody (BV13; Biolegend) via retro-orbital sinus injection, mice were
killed and perfused via intracardiac injection with PBS (pH 7.2). Femurs were ﬁxed
overnight with 4% PFA in PBS (pH 7.2), washed in PBS (pH 7.2) and decalciﬁed
for 72 h in 10% EDTA at room temperature. Femurs were washed in PBS (pH 7.2),
cryopreserved in 30% sucrose for 48 h at 4 C, and embedded in 50% optimal
cutting temperature (OCT). (Tissue-Tek) and 50% sucrose. Sections (12 mm) were
cut on a CM 3050S Cryostat (Leica). For staining, femurs were blocked for 30min
at room temperature in 10% normal goat serum (Jackson ImmunoResearch
Laboratories, Inc), 0.1% Triton X-100, and aCD16/32 at 1:50 (citrulline/PLIN1) or
10% normal donkey serum (Jackson ImmunoResearch Laboratories, Inc), 0.1%
Triton X-100, and aCD16/32 at 1:50 (LEPR), and stained in blocking buffer with
antibodies raised against citrulline at 1:300 (EMD Millipore), PLIN1 at 1:100
(Sigma), or Alexa Fluor 594 (Life Technologies) pre-conjugated LEPR at 1:50
(R&D Systems) overnight at 4 C. Sections were washed in PBS (pH 7.2) and
citrulline/PLIN1 sections were incubated in blocking buffer with goat anti-rabbit
Alexa Fluor 594 at 1:250 (Life Technologies) for 30min at room temperature.
All tissues were counterstained with DAPI at 1 mgml 1 and mounted using
Prolong Gold anti-fade solution (Life Technologies). Longitudinal femur sections
were imaged on a LSM 710 confocal microscope (Zeiss).
lCT analysis. A Scanco Medical mCT 35 system with an isotropic voxel size of
7 mm was used to image the distal femur. Scans used an X-ray tube potential of
55 kVp, an X-ray intensity of 0.145mA and an integration time of 600ms. For
trabecular bone analysis, an upper 2.1-mm region beginning 280mm proximal to
the growth plate was contoured. For cortical bone analysis, a region 0.6mm in
length centered on the midshaft was used. Trabecular and cortical bones were
thresholded at 211 and 350mgHA cm 3, respectively. Three-dimensional images
were obtained from contoured two-dimensional images by methods based on
distance transformation of the binarized images. All images presented are
representative of their respective experimental groups.
Plasma cytokine analysis. Whole blood was collected via retro orbital bleeds
using 150mm heparinized glass capillary tubes (Kimble Chase) into 20 ml of 10mM
EDTA in PBS (pH 7.2) and centrifuged at 1,000 g for 15min at 4 C. Resulting
plasma supernatants were stored at  80 C. Plasma was analysed using the
Luminex xMAP platform (EMD Millipore) according to the manufacturer
instructions. In short, plasma samples were diluted 1:2 in assay buffer and analysed
using the following mouse panels: Mouse Angiogenesis/Growth Factor Magnetic
Bead Panel, including TNFa, IL1b, IL6, G-CSF, SDF1a, FGF2, ANGPT2, EGF,
MCP1, Endothelin-1 and Endoglin (EMD Millipore; MAGPMAG-24K) or Mouse
Cytokine/Chemokine Magnetic Bead Panel, including IL3, IFNg, GM-CSF, and
M-CSF (EMD Millipore; MCYTOMAG-70K). Samples were run using the
Luminex FLEXMAP 3D system and resulting data was analysed with MILLIPLEX
Analyst Software.
BMEC transplantation. C57BL/6J mice were subjected to a myeloablative dose of
total body g-irradiation (700 Rads) in which 50% of untreated mice succumb to
haematopoietic failure (LD50; optimal dosing determined in-house). C57BL/6J
irradiated recipients were transplanted with 5 105 WT BMECs, 5 105
Tie2::IkB-SS cultured BMECs or PBS (carrier) controls on four successive days via
retro-orbital sinus injection following total body irradiation. Mice were monitored
for survival and haematopoietic recovery at indicated time points post-irradiation.
Statistics. No statistical models were employed to predetermine experimental
sample sizes. Signiﬁcance of pairwise comparisons were determined using unpaired
Student’s t-tests, with a signiﬁcance threshold set at Po0.05. All values are
presented as mean±s.e.m. Survival curve signiﬁcance was calculated using the
log-rank test.
Data availability. The authors declare that the data supporting the ﬁndings within
this study are available within the manuscript and its Supplementary Files and are
also available from the corresponding author upon reasonable request.
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